Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide

Impacto

Downloads

Downloads per month over past year

Moya Montes, Marta and San Felipe Riba, Diego and Ballesta, Javier Antonio and Alen Fariñas, Francisco and Rodríguez de Fonseca, Fernando and García Bueno, Borja and Marco López, Eva María and Orio Ortiz, Laura (2020) Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 108 (110190). pp. 1-15. ISSN 0278-5846

[thumbnail of Moya, Marta et al. 2020. Cerebellar and cortical TLR4 activation....pdf] PDF
Restringido a Repository staff only

4MB

Official URL: https://doi.org/10.1016/j.pnpbp.2020.110190



Abstract

Wernicke-Korsakoff Syndrome (WKS) is a neuropsychiatric disorder whose etiology is a thiamine deficiency (TD), with alcoholism being the main underlying cause. Previous evidence suggests the presence of initial neuroinflammation and oxidative/nitrosative stress in the physiopathology, although the specific molecular mechanisms underlying TD-induced brain damage and behavioral disabilities are unknown.
We explored the specific role of the innate immune receptor TLR4 in three murine models of WKS, based on the combination of a thiamine-deficient diet and pyrithiamine injections (0.25 mg/kg, i.p.) over time. The Symptomatic Model (SM) allowed us to describe the complete neurological/neurobehavioral symptomatology over 16 days of TD. Animals showed an upregulation of the TLR4 signaling pathway both in the frontal cortex (FC) and cerebellum and clear motor impairments related with cerebellar dysfunction. However, in the Pre-Symptomatic Model (PSM), 12 days of TD induced the TLR4 pathway upregulation in the FC, which correlated with disinhibited-like behavior, but not in the cerebellum, and no motor impairments. In addition, we tested the effects of the biolipid oleoylethanolamide (OEA, 10 mg/kg, i.p., once daily, starting before any symptom of the pathology is manifested) through the Glucose-Precipitated Model (GPM), which was generated by glucose loading (5 g/kg, i.v., last day) in thiamine-deficient animals to accelerate damage. Pretreatment with OEA prevented the TLR4-induced signature in the FC, as well as an underlying incipient memory disability and disinhibited-like behavior.
This study suggests a key role for TLR4 in TD-induced neuroinflammation in the FC and cerebellum, and it reveals different vulnerability of these brain regions in WKS over time. Pre-treatment with OEA counteracts TD-induced TLR4-associated neuroinflammation and may serve as co-adjuvant therapy to prevent WKS-induced neurobehavioral alterations.


Item Type:Article
Uncontrolled Keywords:Wernicke-Korsakoff syndrome; Thiamine deficiency; Innate immunity; Frontal cortex; Cerebellum; Oleoylethanolamide
Subjects:Medical sciences > Biology > Animal physiology
Medical sciences > Biology > Neurosciences
ID Code:64926
Deposited On:16 Apr 2021 12:33
Last Modified:17 Apr 2021 09:29

Origin of downloads

Repository Staff Only: item control page